Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunopotentiating conjugates.

D E Stewart-Tull

    Vaccine
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Researchers are exploring new ways to create effective cancer immunotherapy vaccines. This involves using immunopotentiating agents and presenting peptide antigens using carrier proteins or liposomes to boost immune responses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Production of Polyclonal Antibodies in Laboratory Animals. The Report and Recommendations of ECVAM Workshop 35.

    Alternatives to laboratory animals : ATLA·2014
    Same author

    Comparative bactericidal activities of lasers operating at seven different wavelengths.

    Journal of biomedical optics·2012
    Same author

    Temperature distribution in Escherichia coli liquid suspensions during irradiation by a high-power Nd:YAG laser for sterilization applications.

    Journal of biomedical optics·2012
    Same author

    The use of adjuvants in experimental vaccines : I. Aluminum hydroxide gels.

    Methods in molecular medicine·2011
    Same author

    The Use of Adjuvants in Experimental Vaccines : II. Water-in-Oil Emulsions: Freund's Complete and lncomplete Adjuvants.

    Methods in molecular medicine·2011
    Same author

    The Use of Adjuvants in Experimental Vaccines : III. Liposomes.

    Methods in molecular medicine·2011

    Area of Science:

    • Immunology
    • Vaccine Development
    • Cancer Immunotherapy

    Background:

    • Growing interest in sub-cellular vaccines and cancer immunotherapy.
    • Peptide antigens are often small and non-immunogenic alone.
    • Need for effective antigen presentation strategies.

    Purpose of the Study:

    • To explore methods for enhancing the immunogenicity of peptide antigens.
    • To investigate the use of immunopotentiating agents in vaccine development.
    • To evaluate liposomes as a delivery system for peptide antigens.

    Main Methods:

    • Synthesizing or genetically engineering peptide sequences.
    • Conjugating protective antigens with carrier proteins and/or immunopotentiators.
    • Incorporating hydrophobic peptide sequences into artificial lipid bilayers (liposomes).

    Related Experiment Videos

    Main Results:

    • Experimental studies demonstrate the potential of conjugated vaccines.
    • Liposomal presentation offers an alternative method for antigen delivery.
    • These approaches aim to overcome the non-immunogenic nature of small peptides.

    Conclusions:

    • Conjugated vaccines with carrier proteins or immunopotentiators are promising.
    • Liposomal delivery systems provide a viable strategy for presenting peptide antigens.
    • These methods are crucial for advancing cancer immunotherapy and vaccine development.